Cargando…

The role of clopidogrel resistance-related genetic and epigenetic factors in major adverse cardiovascular events among patients with acute coronary syndrome after percutaneous coronary intervention

Despite patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) and receiving clopidogrel therapy, some patients still experience major adverse cardiovascular events (MACEs). Clopidogrel resistance, which may be regulated by genetic and epigenetic factors, may...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giantini, Astuti, Timan, Ina S., Dharma, Rahajuningsih, Sukmawan, Renan, Setiabudy, Rianto, Alwi, Idrus, Harahap, Alida R., Listiyaningsih, Erlin, Partakusuma, Lia G., Tansir, Arif R., Sahar, Windy, Hidayat, Rakhmad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944402/ https://www.ncbi.nlm.nih.gov/pubmed/36843628 http://dx.doi.org/10.3389/fcvm.2022.1027892

Ejemplares similares

Increase in the risk of clopidogrel resistance and consequent TIMI flow impairment by DNA hypomethylation of CYP2C19 gene in STEMI patients undergoing primary percutaneous coronary intervention (PPCI)
por: Sukmawan, Renan, et al.
Publicado: (2021)

Correlation P2Y12 Genetic Polymorphism As Risk Factor of Clopidogrel Resistance in Indonesian Stroke Patients
por: Hidayat, Rakhmad, et al.
Publicado: (2023)

Clopidogrel Resistance Among Ischemic Stroke Patients and Its Risk Factors in Indonesia
por: Hidayat, Rakhmad, et al.
Publicado: (2022)

Evaluation of loop-mediated isothermal amplification for detecting COVID-19
por: Giantini, Astuti, et al.
Publicado: (2023)

The association of apolipoprotein in the risk of ST-elevation myocardial infarction in patients with documented coronary artery disease
por: Giantini, Astuti, et al.
Publicado: (2023)

Combined transepicardial and transseptal implantation of autologous CD 133+ bone marrow cells during bypass grafting improves cardiac function in patients with low ejection fraction
por: Soetisna, Tri Wisesa, et al.
Publicado: (2020)

Effectiveness of Cimetidine as Adjuvant Therapy in the Treatment of Acute-Extrinsic Atopic Dermatitis: A Double-Blind Randomized Controlled Trial
por: Novianto, Endi, et al.
Publicado: (2022)

The role of the glucocorticoid receptor and its impact on steroid response in moderate-severe COVID-19 patients
por: Aliska, Gestina, et al.
Publicado: (2023)

Longer Hydroxyurea Administration Prior to Imatinib Mesylate is Risk Factor for Unsuccessful Major Molecular Response in Chronic-Phase Chronic Myeloid Leukemia: Possibility of P-Glycoprotein Role
por: Rinaldi, Ikhwan, et al.
Publicado: (2019)

Association of microRNA-224-3p and microRNA-155-5p expressions with plasma long pentraxin 3 concentration and coronary microvascular obstruction following primary angioplasty for acute ST-segment elevation myocardial infarction
por: Dharma, Surya, et al.
Publicado: (2020)

Correlation of Inflammation and Coagulation Markers with the Incidence of Deep Vein Thrombosis in Cancer Patients with High Risk of Thrombosis
por: Setiawan, Budi, et al.
Publicado: (2022)

An Examination of Clopidogrel in the Treatment of Coronary Microvascular Disease
por: Iskandar, Nicholas P, et al.
Publicado: (2022)

Factors Affecting the Self-Isolation Monitoring Program for COVID-19 Patients at the Universitas Indonesia Hospital
por: Hidayat, Rakhmad, et al.
Publicado: (2022)

Acute Ischaemic Stroke Incidence after Coronavirus Vaccine in Indonesia: Case Series
por: Hidayat, Rakhmad, et al.
Publicado: (2021)

Determinants to optimize response to clopidogrel in acute coronary syndrome
por: Giusti, Betti, et al.
Publicado: (2010)

Comparison of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention
por: Norgard, Nicholas B, et al.
Publicado: (2009)

New Insight into the Molecular Drug Target of Diabetic Nephropathy
por: Soetikno, Vivian, et al.
Publicado: (2014)

Effects of Ticagrelor versus Clopidogrel in Patients with Coronary Bifurcation Lesions Undergoing Percutaneous Coronary Intervention
por: Zheng, Wei, et al.
Publicado: (2019)

Aspirin and clopidogrel hyporesponsiveness and nonresponsiveness in patients with coronary artery stenting
por: Sharma, Rakesh K, et al.
Publicado: (2009)

Pharmacoeconomic Analysis of Clopidogrel in Secondary Prevention of Coronary Artery Disease
por: Cheng, Judy W.
Publicado: (2007)

Efficacy and Safety of Ticagrelor and Clopidogrel in Patients with Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
por: Li, Jianan, et al.
Publicado: (2021)

Ticagrelor vs. Clopidogrel After Complex Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease
por: Xi, Ziwei, et al.
Publicado: (2021)

The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423]
por: Kulik, Alexander, et al.
Publicado: (2005)

Surveillance of Adverse Events Following Immunization (AEFI) after Third Dose Booster Vaccination with mRNA-Based Vaccine in Universitas Indonesia Hospital Health Personnel
por: Hidayat, Rakhmad, et al.
Publicado: (2022)

The effectiveness of atorvastatin for the prevention of deep vein thrombosis in cancer patients undergoing chemotherapy: A randomised controlled trial: open label
por: Setiawan, Budi, et al.
Publicado: (2023)

Use of clopidogrel in the reduction of myocardial damage during percutaneous coronary intervention
por: Dasgupta, Arijit, et al.
Publicado: (2009)

Clopidogrel: A Pharmacogenomic Perspective on its Use in Coronary Artery Disease
por: Terpening, Chris
Publicado: (2010)

Comparison of Ticagrelor and Clopidogrel for Patients Undergoing Emergency Percutaneous Coronary Intervention
por: YANG, Bin, et al.
Publicado: (2018)

A Review of Danshen Combined with Clopidogrel in the Treatment of Coronary Heart Disease
por: Zhang, Zhaojian, et al.
Publicado: (2019)

Optimal Duration for Clopidogrel Suspension Prior to Coronary Artery Bypass Grafting
por: Ullah, Waqas, et al.
Publicado: (2019)

Comparison of ticagrelor with clopidogrel on quality of life in patients with acute coronary syndrome
por: Moon, Hyeyeon, et al.
Publicado: (2021)

Effects of Ticagrelor and Clopidogrel on Coronary Microcirculation in Patients with Acute Myocardial Infarction
por: Scanavini-Filho, Marco Antonio, et al.
Publicado: (2022)

Effect of primary balloon angioplasty on draining vein diameter and volume flow in patients with arteriovenous fistula: A cohort study
por: Suhartono, R., et al.
Publicado: (2022)

Optimal strategy of switching from clopidogrel to ticagrelor in Chinese acute coronary syndrome patients with complicated coronary artery disease: the switching from clopidogrel to ticagrelor (SHIFT-CACS) study
por: Yao, Ying, et al.
Publicado: (2019)

Iron Absorption in Iron-Deficient Women, Who Received 65 mg Fe with an Indonesian Breakfast, Is Much Better from NaFe(III)EDTA than from Fe(II)SO(4), with an Acceptable Increase of Plasma NTBI. A Randomized Clinical Trial
por: Ginanjar, Eka, et al.
Publicado: (2018)

Clopidogrel-Induced Neutropenia after Coronary Stenting: Is Cilostazol a Good Alternative?
por: Montalto, Massimo, et al.
Publicado: (2011)

Cost-effectiveness of ticagrelor versus clopidogrel in patients with acute coronary syndromes in Canada
por: Grima, Daniel T, et al.
Publicado: (2014)

Clopidogrel versus Ticagrelor for Secondary Prevention after Coronary Artery Bypass Grafting
por: Chang, Hyoung Woo, et al.
Publicado: (2019)

Effects of switching ticagrelor to clopidogrel on cardiovascular outcomes in patients with acute coronary syndrome
por: Liu, Lin, et al.
Publicado: (2018)

Effect of Ticagrelor Versus Clopidogrel on Aortic Stiffness in Patients With Coronary Artery Disease
por: Vlachopoulos, Charalambos, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7hssq1phjvuqi5kqnhau0c1pbk